Cargando…

Determinants and Equity Evaluation for Health Expenditure Among Patients with Rare Diseases in China

BACKGROUND: China has not established social security system for rare diseases. Rare diseases could easily impoverish patients and their families. Little research has studied the equity and accessibility of health services for patients with rare diseases in China. This study aimed to explore the fac...

Descripción completa

Detalles Bibliográficos
Autores principales: Xin, Xiao-Xiong, Zhao, Liang, Guan, Xiao-Dong, Shi, Lu-Wen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4910359/
https://www.ncbi.nlm.nih.gov/pubmed/27270531
http://dx.doi.org/10.4103/0366-6999.183425
_version_ 1782438006118940672
author Xin, Xiao-Xiong
Zhao, Liang
Guan, Xiao-Dong
Shi, Lu-Wen
author_facet Xin, Xiao-Xiong
Zhao, Liang
Guan, Xiao-Dong
Shi, Lu-Wen
author_sort Xin, Xiao-Xiong
collection PubMed
description BACKGROUND: China has not established social security system for rare diseases. Rare diseases could easily impoverish patients and their families. Little research has studied the equity and accessibility of health services for patients with rare diseases in China. This study aimed to explore the factors that influence health expenditure of rare diseases and evaluate its equity. METHODS: Questionnaire survey about living conditions and cost burden of patients with rare diseases was conducted. Individual and family information, health expenditure and reimbursement in 2014 of 982 patients were collected. The impact of medical insurance, individual sociodemographic characteristics, family characteristics, and healthcare need on total and out-of-pocket (OOP) health expenditures was analyzed through the generalized linear model. Equity of health expenditure was evaluated by both concentration index and Lorenz curve. RESULTS: Of all the surveyed patients, 11.41% had no medical insurance and 92.10% spent money to seek medical treatment in 2014. It was suggested female (P = 0.048), over 50 years of age (P = 0.062), high-income group (P = 0.021), hospitalization (P = 0.000), and reimbursement ratio (RR) (P = 0.000) were positively correlated with total health expenditure. Diseases not needing long-term treatment (P = 0.000) was negatively correlated with total health expenditure. Over 50 years of age (P = 0.065), high-income group (P = 0.018), hospitalization (P = 0.000) and having Urban Employee Basic Medical Insurance (UEBMI) (P = 0.022) were positively correlated with OOP health expenditure. Patient or the head of the household having received higher education (P = 0.044 and P = 0.081) and reimbursement ratio (P = 0.078) were negatively correlated with OOP health expenditure. The equity evaluation found concentration indexes of health expenditure before and after reimbursement were 0.0550 and 0.0539, respectively. CONCLUSIONS: OOP health expenditure of patients with UEBMI was significantly more than that of patients without medical insurance. However, for any other medical insurance, there was no difference between OOP health expenditure of the insured patients and patients without insurance. The current reimbursement policies have increased the equity of health expenditure, but are biased toward high-income people.
format Online
Article
Text
id pubmed-4910359
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-49103592016-06-20 Determinants and Equity Evaluation for Health Expenditure Among Patients with Rare Diseases in China Xin, Xiao-Xiong Zhao, Liang Guan, Xiao-Dong Shi, Lu-Wen Chin Med J (Engl) Original Article BACKGROUND: China has not established social security system for rare diseases. Rare diseases could easily impoverish patients and their families. Little research has studied the equity and accessibility of health services for patients with rare diseases in China. This study aimed to explore the factors that influence health expenditure of rare diseases and evaluate its equity. METHODS: Questionnaire survey about living conditions and cost burden of patients with rare diseases was conducted. Individual and family information, health expenditure and reimbursement in 2014 of 982 patients were collected. The impact of medical insurance, individual sociodemographic characteristics, family characteristics, and healthcare need on total and out-of-pocket (OOP) health expenditures was analyzed through the generalized linear model. Equity of health expenditure was evaluated by both concentration index and Lorenz curve. RESULTS: Of all the surveyed patients, 11.41% had no medical insurance and 92.10% spent money to seek medical treatment in 2014. It was suggested female (P = 0.048), over 50 years of age (P = 0.062), high-income group (P = 0.021), hospitalization (P = 0.000), and reimbursement ratio (RR) (P = 0.000) were positively correlated with total health expenditure. Diseases not needing long-term treatment (P = 0.000) was negatively correlated with total health expenditure. Over 50 years of age (P = 0.065), high-income group (P = 0.018), hospitalization (P = 0.000) and having Urban Employee Basic Medical Insurance (UEBMI) (P = 0.022) were positively correlated with OOP health expenditure. Patient or the head of the household having received higher education (P = 0.044 and P = 0.081) and reimbursement ratio (P = 0.078) were negatively correlated with OOP health expenditure. The equity evaluation found concentration indexes of health expenditure before and after reimbursement were 0.0550 and 0.0539, respectively. CONCLUSIONS: OOP health expenditure of patients with UEBMI was significantly more than that of patients without medical insurance. However, for any other medical insurance, there was no difference between OOP health expenditure of the insured patients and patients without insurance. The current reimbursement policies have increased the equity of health expenditure, but are biased toward high-income people. Medknow Publications & Media Pvt Ltd 2016-06-20 /pmc/articles/PMC4910359/ /pubmed/27270531 http://dx.doi.org/10.4103/0366-6999.183425 Text en Copyright: © 2016 Chinese Medical Journal http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
spellingShingle Original Article
Xin, Xiao-Xiong
Zhao, Liang
Guan, Xiao-Dong
Shi, Lu-Wen
Determinants and Equity Evaluation for Health Expenditure Among Patients with Rare Diseases in China
title Determinants and Equity Evaluation for Health Expenditure Among Patients with Rare Diseases in China
title_full Determinants and Equity Evaluation for Health Expenditure Among Patients with Rare Diseases in China
title_fullStr Determinants and Equity Evaluation for Health Expenditure Among Patients with Rare Diseases in China
title_full_unstemmed Determinants and Equity Evaluation for Health Expenditure Among Patients with Rare Diseases in China
title_short Determinants and Equity Evaluation for Health Expenditure Among Patients with Rare Diseases in China
title_sort determinants and equity evaluation for health expenditure among patients with rare diseases in china
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4910359/
https://www.ncbi.nlm.nih.gov/pubmed/27270531
http://dx.doi.org/10.4103/0366-6999.183425
work_keys_str_mv AT xinxiaoxiong determinantsandequityevaluationforhealthexpenditureamongpatientswithrarediseasesinchina
AT zhaoliang determinantsandequityevaluationforhealthexpenditureamongpatientswithrarediseasesinchina
AT guanxiaodong determinantsandequityevaluationforhealthexpenditureamongpatientswithrarediseasesinchina
AT shiluwen determinantsandequityevaluationforhealthexpenditureamongpatientswithrarediseasesinchina